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Immunohistochemical detection of GFAP and TGF β1 in C57Bl6
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Detecção imunoistoquímica de TGF-BETA e GFAP em camundongos
C57Bl6 com encefalite aguda induzida pelo vírus da estomatite vesicular
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Candioto1, Luciana Mari Ushiro Ieiri1 & Antonio Carlos Alessi3
ABSTRACT
Activation of astrocytes or astrogliosis is a prominent component of the inflammatory response and an indicator of
injury in the brain. These astrocytes produce a large array of inflammatory mediators, growth and neuroprotective factors. This
study was an investigation from astrocyte (GFAP) response and TGF-β1 involvement during VSV acute encephalitis using immu-
nohistochemistry to verify relation between astrocytes and TGF-β1. Animals developed symptoms around 6th day after VSV
inoculation. Viral proteins were mainly detected at olfactory bulb, ventricular cell layer and disseminated to hippocampus,
mesencephalon and diecephalon areas and brain stem. Also at 6th day post inoculation GFAP and TGF-β1 staining was obser-
ved in good association with virus-detected areas of brain. However, in mice with severe symptoms we observed reduction in
the intensity of GFAP labeling at the same areas where TGF-β1 upregulation was observed. These areas show correlation with areas
of necrosis and where are astrocytes with degenerative aspect. We observed TGF-β1 staining in damaged astrocytes, suggesting
an effort of those cells in controlling inflammation in acute phase of VSV encephalitis.
Key words: astrocytes, gliosis, TGF-β, vesicular stomatitis virus.
RESUMO
Ativação de astrócitos ou astrogliose é um componente evidente da resposta inflamatória e um indicador de injúria
no sistema nervoso. Estes astrócitos produzem uma grande combinação de mediadores inflamatórios, fatores de crescimento
e neuroprotetores. Este trabalho investiga a resposta de astrócitos (GFAP) e a participação de TGF-β1 durante a fase aguda da
encefalite por VSV usando imunoistoquímica para verificar a relação entre astrócitos e TGF-β1. Os camundongos desenvolve-
ram sintomas cerca de 6 dias após a inoculação (pi) do VSV. As proteínas virais foram detectadas principalmente no bulbo olfa-
tório, células ventriculares e disseminadas em áreas do hipocampo, mesencéfalo e diencéfalo. Também no sexto dia pi, a mar-
cação para GFAP e TGF-β1 foi observada associada com áreas onde o vírus foi detectado. Entretanto, em camundongos com
sintomas severos, nós observamos áreas onde a marcação para TGF-β1 foi mais intensa. Estas áreas apresentaram correlação
com áreas de necrose, onde astrócitos degenerados foram observados. A marcação para TGF-β1 em astrócitos lesados, sugeriu um
esforço destas células em controlar a inflamação na fase aguda da encefalite por VEV.
Descritores: astrócitos, Gliose, TGF-β1, vesicular estomatite vírus.
Acta Scientiae Veterinariae. 34(1): 83-88, 2006.
ORIGINAL ARTICLE
Pub. 657
ISSN 1678-0345 (Print)
ISSN 1679-9216 (Online)
1UNESP – São Paulo State University, School of Veterinary Medicine, Araçatuba, Department of Clinical Surgery and Animal Reproduction.
2USP – FMVZ – São Paulo, Department of Pathology. 3UNESP-FCAV-Jaboticabal, Department of Veterinary Pathology. CORRESPONDENCE:
G.F. Machado [giselem@fmva.unesp.br].
Received: December 2005 Accepted: March 2006www.ufrgs.br/favet/revista
84
Machado G.F., Maiorka P.C., Candioto C.G., Ieiri L.M.U. & Alessi A.C. 2006. Immunohistochemical detection of GFAP and TGF
β1 in C57Bl6 mice during acute vesicular stomatitis virus encephalitis. Acta Scientiae Veterinariae. 34: 83-88.
INTRODUCTION
Activation of astrocytes or astrogliosis is a pro-
minent component of the inflammatory response and
an indicator of injury in the brain. These astrocytes pro-
duce a large array of inflammatory mediators, growth
and neuroprotective factors [29,30]. Communication
between astrocytes and astrocytes or others cells in
CNS occurs by gap junctions and it could result in a
favorable metabolic co-operation [2]. Whereas some
of these effects are clearly beneficial, astrocyte commu-
nication could mediate additional death of the adjacent
cells by the bystander effect [2].
Mice with moderate or low levels of TGF-β1
expression had a less pronounced astrogliosis, whereas
GFAP expression was consistently increased [28]. Indeed,
TGF-β1 directly increases GFAP transcription in cul-
tured astrocytes [22]. Studies on cultured neurons show
a protective effect of TGF-1 against various toxins and
injurious agents. Little is known about TGF-β1 rules
during acute phase of CNS injuries in an animal model
[reviewed in 25].
Mice experimental infection of vesicular sto-
matitis virus by the intranasal route results in spread
by retrograde transport in neurons and ventricular sur-
faces [12,20]. Current data suggests that acute encepha-
litis induces apoptosis, tissue injury, and mortality in
VSV-infected mice [24].
The aim of the present study was to investigate
the possible correlation between astrocytes (GFAP) and
TGFβ1 during acute phase of vesicular stomatitis virus
encephalitis comparing the localization of both pro-
teins in encephalon of symptomatic and assymptomatic
mice.
MATERIALS AND METHODS
Virus
The sample of vesicular stomatitis virus, strain
Indiana type II was maintained at -80ºC in BHK. Mouse
brain suspension used for inoculation was obtained from
intracerebral inoculation of mice as previous described
[20]. The VSV titration was determined as infecting dose
per tissue culture (TCID50/0.1 ml) expressed in deci-
mal logarithms was 105 virus/0,1ml.
Experimental infection of mice
Thirty male C57BI6 mice, 5 to 7 weeks old
(CEMIB-UNICAMP-SP-Brazil), were used for viral
inoculation. Mice were mildly anesthetized in a closed
container with ether followed by intranasal inoculation
with VSV suspension (105 virus/0.1ml) in a total volu-
me of 0.03ml administered equally between each nostril
according to [11]. Five mice got sterile PBS into the
nostril were used as control (Group 1). Animals were
housed with food and water ad libidum and were ran-
domly sacrificed for histological and immunohistoche-
mical analysis at day 6, symptomatic mice comprised
Group 2, and assymptomatic mice, Group 3. Each group
was composed by at least 6 mice. All the protocols were
approved and experiments were carried out in agree-
ment with UNESP- Animal Ethic in Animal Experimen-
tation Committee for animal care.
Histological and Immunohistochemical analysis
Mice were anesthetized with ether and sacri-
ficed with intraperitoneal lethal dose of 5mg of pento-
barbital sodium (Nembutal®1 - Abbott Laboratories)
in normal saline solution. Each mouse was perfused
transcardially with 30-40ml of phosphate-buffered
saline (PBS pH 7.4). After perfusion whole brains were
removed and fixed during 8 hours in freshly prepared
4% buffered paraformaldehyde (pH 7.4) and embedded
in paraffin according to standard procedures. Selected
areas were based on viral dissemination route described
by [12,20].
Five-micrometer brain longitudinal sections
were stained with hematoxylin and eosin in order to
detect inflammatory, degenerative or reactive features
of neurons. For immunohistochemistry, endogenous
peroxidase activity was blocked by incubating sections
in 1% H2O2. Sections were treated with Tripsin 1% at
37oC before blocking of nonspecific binding with pow-
dered skimmed milk (3% in phosphate-buffered saline)
for 30 minutes. Incubation with primary antibodies was
performed overnight at at 4ºC. For demonstration of
astrocytes morphology polyclonal anti-GFAP was used
(1:400, Dako2) and for characterization of TGF-β1 dis-
tribution we used anti-TGF-β1 (Santa Cruz3, SC-146).
Biotinylated anti-rabbit (1:100, Dako2) and anti-goat
(Santa-Cruz, 1:100) was applied as secondary anti-
bodies and avidin-biotin-peroxidase complex (ABC
kit, Vector Laboratories, USA) served as the third rea-
gent. Positive antigen-antibody reaction was visualized
by incubation with 3.3-diaminobenzidine-tetrahydro-
cloride-(DAB)-H2O2 followed by counterstain with
Mayer hematoxilin. Negative control sections were
incubated in the absence of the primary antibody.
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RESULTS
Clinical signs
Six inoculated mice showed signs of disease
at 6th day post inoculation (pi). Typical clinical signs
included ruffled fur, conjunctivitis, reduced mobility
and progressive posterior paralysis. To minimize suffe-
ring to the animals they were sacrificed at start of the
paralysis symptoms.
Histopathology
Brains observed at 6th day post inoculation
showed intense inflammation in the olfactory bulb.
Leptomeningitis, which the intensity varied from mild
to intense, was observed at olfactory bulb and extended
to encephalic ventral surface. Most affected mice showed
necrosis at olfactory bulb and also ventriculitis at la-
terals, third and fourth ventricles affecting subepen-
dymal layer (Figure 1A). Perivascular infiltrates and
necrosis was also observed at thalamus, hypothalamus
and brain stem. Inflammatory infiltrates were compo-
sed by neutrophils and lymphocytes.
Immunohistochemistry for viral antigen
Six days after nasal instillation, in symptomatic
mice (Group 3), VSV proteins were detected at olfac-
tory bulb, ependymal and subependymal layers, hyppo-
campal, hypothalamic and thalamic areas, some nucleus
at mesencephalon and brain stem. Cerebellum and cor-
tical areas were less affected (Figure 1D).
Immunohistochemistry for GFAP
Astrocytes positive for GFAP were
easily identified in animals of all groups
(Table 1). Reactive astrocytes were charac-
terized mainly for having large and clear
nucleus, clumped chromatin located peri-
pherally, and large nucleoli. The cytoplasm
was evident and the thick processes were
intensively stained. Cells with those charac-
teristics were observed mainly in the glo-
merular and mitral cell layers of olfactory
bulb, even in assymptomatic mouse sacri-
ficed at day 6-post inoculation. Mice pre-
senting symptoms sacrificed at day 6th
showed astrogliosis in other encephalic
areas as glia limitans externa, glia limitans
interna, hippocampus, diencephalon and
mesencephalon.
Strong to intense GFAP reactivity
was characteristic on symptomatic mouse
(Table 1), apart from reduction in the intensity of the
reaction in some areas of the encephalon that corres-
ponds to necrotic areas of olfactory bulb and around
ventricular areas. GFAP-positive cells, with large swollen
nuclei, evident nucleoli and processes with a fragmented
feature were observed in areas where inflammation was
intense and necrosis could also observed (Figure 1C
and F). Surrounding necrotic tissue there was a tran-
sitional area where astrocytes showed less marked dege-
nerative morphological aspects, i.e., the processes were
short, thick and showed only a mild fragmentation.
Immunohistochemistry for TGF-β
TGF β1 immunorreactivity was observed at lep-
tomeninges, at ependymal and subependymal cells and
choroid plexus in control group (Group 1). Six days
post VSV inoculation TGF-β upregulation was observed
in encephalon associated to inflammation and VSV
dissemination. Immunostaining was positive in neurons
and astrocytes at olfactory bulb, in cells at subepen-
dymal area, in neurons and astrocytes of hippocam-
pus and brain stem. Leptomeninges and choroid plexus
epithelium showed positive staining, as some inflamma-
tory cell at subpial and perivascular space. At olfac-
tory bulb (Figure 1E) and periventricular ependymal
and subependymal layer (Figure 1B) some structures
similar to astrocytes processes also were marked. Positive
extra cellular diffuse staining was also observed.
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Table 1. General immunohistochemical staining patterns distribution for
GFAP and TGF-β on brain of mice inoculated and sacrificed at 6 days post
inoculation and controls.
(-) no staining; (+) weak staining; (+ +) moderate staining; (+ + +) strong staining; (+
+ + +) intense staining. Group 1: Control; Group 2 : with symptoms at 6th day; Group
3: without symptoms at 6th day.
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DISCUSSION
Similar to the rabies virus, VSV presents neuro-
tropism and the neuronal infection results in cell death.
Acute CNS major lesion in VSV infection includes lep-
tomeningitis and ventriculitis, followed by neuronal
damage and a parallel glial activation. Viral migration
in the course of infection occurs via olfactory tracts
and ventricles surface, involving hippocampus, dien-
cephalon, mesencephalon, and brain stem [12, 20].
In mice sacrificed on day 6 without symptoms,
the tissue injury was less intense and mainly limited
to the olfactory bulb, where GFAP-positive astrocytes
with activated morphology were observed. In those
mice viral proteins were detected essentially in olfac-
Figure 1. A, B and C - Serial sections of an infected brain removed at day six. A - Cells at subependymal layer showing signs of cell
death (HE, bar = 25µm). B - TGF-β immunohistochemistry at subependyaml layer of lateral venticle (bar = 25µm). C - GFAP stai-
ning. Note attenuation of GFAP positivity inside square demarcated area (bar = 50µm). D - Distribution of VSV antigen in sagital
seciton of brain 6 days post inoculation. (OB) Olfactory bulb; (T) thalamus; (H) hypocampus formation; (Hy) hypothalamus; (M)
mesencephalum; (Cb) cerebellum; (Br) brainstem (bar = 1mm). E and F - Serial sections of olfactory bulb. E - TGF-β intense staining
at astrocytes (arrows) (bar = 25µm). F - Decreasing in GFAP detection. Only few structures are marked (arrows) (bar = 25µm).
A
B
C
E
F
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tory bulb. In symptomatic mice at 6th day after virus
inoculation reactive astrocytes were detected in the
olfactory bulb and other areas such as hippocampus,
mesencephalic and diencephalic areas and brain stem,
thus confirming the observations of de [5,20,26], which
described rapid response to VSV infection, both from
astrocytes and also microglia activation. Areas where
the down regulation of GFAP labeling was detected
corresponded to sites where there was tissue necrosis,
intense viral and TGFβ1 detection.
Astrocytes are important cells contributing to
immune response, and also for healing and/or rege-
neration of nervous tissue. Down regulation of GFAP
associated with morphological changes are a strong indi-
cative of astrocyte degeneration. Morphological changes
observed in nervous tissue, including those observed
in astrocytes at 6th day pi may be caused by virus multi-
plication and beginning of cell death triggered by apop-
tosis [24]. However, neuron and glial cells are very likely
to suffer injury secondary to the inflammatory pro-
cess, as a bystander effect. Astrocyte degenerative chan-
ges might be associated with functional changes, which
might contribute to the aggravation of CNS lesions [4,
21,23].
TGF-β1 has been found in glial cells, Schwann
cells and in certain populations of neurons [9]. Com-
paring with control (Group 1), all groups had stronger
staining, specially those mice with symptoms of Group
3. We observed neuronal cells stained positively for
TGF-β1 at brain steam nucleus at day 6 pi. TGF-β1 ex-
pression in neurons is related with neurodegeneration
[13]. So, in VSV model, TGF-β1 expression in neurons
seems to be related to a response to viral neurotropism.
At olfactory bulb and ependymal and sub-
ependimal layers, crucial areas for virus dissemination,
structures very similar to astrocytes processes presented
TGF-β1 positivity (Figure 1E and F). On sequential sec-
tions, GFAP detection was almost inexpressive and
suggested astrocyte damage. TGF-β1 has been found
mainly in glial cells and is detected in low quantities at
mature CNS. After different injuries TGF-β1 is synthe-
sized by microglia and, at low levels, by astrocytes [1,
8,19]. In particular, astrocytic expression of TGF-β is
a powerful suppressor of microglial cells [10,14,15,18].
Comparing both protein expressions on day six-
post inoculation we noticed a commitment of astro-
cytes in synthesizes TGF-β1 during acute VSV infection.
As general rule, reports with reference to TGFβ1 suggest
the importance of this cytokine in chronic phase of
diseases as modulator molecule witch interfere in cellu-
lar differentiation, extracellular matrix production and
immunological response [3,7,16,17,27]. Recent research
shows the importance of TGF-β1 and its signaling path-
ways as putative modulator of astrocyte biology and
its implication as a possible novel mediator of cellular
interactions in the CNS [6,25]. We observed TGFβ1 stai-
ning in damaged astrocytes, suggesting an effort of those
cells in controlling inflammation in acute phase of VSV
model of viral encephalitis.
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